临床外科杂志 ›› 2022, Vol. 30 ›› Issue (7): 673-676.doi: 10.3969/j.issn.1005-6483.2022.07.022

• 论著 • 上一篇    下一篇

循环miR-485-5p水平与前列腺癌病人病理参数的关系及其对预后的价值

  

  1. 223000 江苏省徐州医科大学附属淮安医院(淮安市第二人民医院)泌尿外科 
  • 收稿日期:2022-01-24 接受日期:2022-01-24 出版日期:2022-07-20 发布日期:2022-07-20
  • 通讯作者: 李强,Email,liuguolu2021@163.com

Relationship between circulating miR-485-5p and pathological parameters in patients with prostate cancer and its prognostic value

  1. Department of Urology,Huai'an Hospital Affiliated to Xuzhou Medical University,Huaian Second People's Hospital,Jiangsu,Huai'an 223000,China
  • Received:2022-01-24 Accepted:2022-01-24 Online:2022-07-20 Published:2022-07-20

摘要: 目的 探讨循环miR-485-5p水平与前列腺癌病人病理参数的关系及其对预后的预测价值。 方法 选取2016年10月~2018年11月我院收治的前列腺癌病人103例,本研究为前瞻性研究,所有病人均行前列腺癌根治性手术治疗,术后随访3年。检测所有病人术前miR-485-5p相对表达量,Cox回归分析影响前列腺癌病人术后复发转移的因素,探讨血清miR-485-5p相对表达量预测前列腺癌病人术后复发转移的价值及其与前列腺癌病人预后的关系。 结果 Gleason评分>7分、有微血管侵犯、有淋巴结转移、Ⅲ期病人的miR-485-5p相对表达量分别低于Gleason评分≤7分、无微血管侵犯、无淋巴结转移、Ⅰ-Ⅱ期病人,差异有统计学意义(P<0.05)。截止随访结束10例病人失访,剩余93例前列腺癌病人中35例出现复发转移。Cox回归分析显示,Gleason评分、分期、miR-485-5p相对表达量是影响前列腺癌病人术后复发转移的独立因素(P<0.05)。ROC曲线结果显示,血清miR-485-5p水平预测前列腺癌病人术后复发转移的灵敏度为74.29%,特异度为75.86%,AUC为0.795。以术前血清miR-485-5p相对表达量预测前列腺癌病人术后复发转移的最佳截断点(1.02)为分界线,41例miR-485-5p低表达病人无病生存21例,52例miR-485-5p高表达病人无病生存37例;miR-485-5p高表达病人的无病生存曲线优于miR-485-5p低表达病人,差异有统计学意义(P<0.05)。 结论 miR-485-5p表达情况与前列腺癌病人病理参数及预后有关,miR-485-5p低表达病人预后不良风险高。

关键词: 前列腺癌, miR-485-5p, 病理, 预后

Abstract: Objective To explore the relationship between circulating miR-485-5p levels and pathological parameters of prostate cancer patients and its prognostic value. Methods A prospective study was conducted on 103 patients with prostate cancer admitted to the hospital from October 2016 to November 2018.All patients underwent radical surgery for prostate cancer and were followed up for 3 years.The relative expression of miR-485-5p was detected in all patients before operation.The relative expression of miR-485-5p in serum of prostate cancer patients with different pathological parameters was analyzed.Factors affecting the recurrence and metastasis of prostate cancer patients were analyzed.The value of serum miR-485-5p relative expression in predicting postoperative recurrence and metastasis of prostate cancer patients was analyzed.The relationship between the relative expression of miR-485-5p and the prognosis of prostate cancer patients was analyzed. Results The relative expression of miR-485-5p in patients with Gleason score>7,microvascular invasion,lymph node metastasis,and stage Ⅲ was lower than Gleason score ≤7 points,no microvascular invasion,no lymph node metastasis,and stage Ⅰ-Ⅱ(P<0.05).As of the end of follow-up,10 patients were lost to follow-up,and 35 of the remaining 93 prostate cancer patients had recurrence and metastasis.Cox regression analysis showed Gleason score,stage,relative expression of miR-485-5p was independent factor affecting postoperative recurrence and metastasis of prostate cancer patients(P<0.05).ROC curve results showed that the sensitivity of serum miR-485-5p level to predict postoperative recurrence and metastasis of prostate cancer patients was 74.29%,and the specificity was 75.86%,AUC was 0.795.The best cut-off point(1.02) for predicting postoperative recurrence and metastasis of prostate cancer patients with the relative expression of preoperative serum miR-485-5p is the dividing line.41 patients with low miR-485-5p expression survived 21 patients,and 52 patients with high miR-485-5p expression survived 37 patients;patients with high miR-485-5p expression had better disease-free survival curves than miR-485 For patients with low expression of -5p(P<0.05). Conclusion The expression of miR-485-5p is related to the pathological parameters and prognosis of prostate cancer patients.Patients with low miR-485-5p expression have a high risk of poor prognosis.

Key words: prostate cancer, miR-485-5p, pathology, prognosis

[1] 原野 刘涛 刘华. 食管鳞癌组织微小RNA-138、微小RNA-145表达水平与1型/2型辅助性T细胞漂移和预后的关系[J]. 临床外科杂志, 2022, 30(8): 744-748.
[2] 罗耀兵 杨武军 王兴平 李美清. 颅内压监测下阶梯减压术对急诊颅脑创伤病人炎症反应、代谢状态及预后的影响[J]. 临床外科杂志, 2022, 30(7): 640-643.
[3] 袁赵 郑昂. 腹腔镜下脾切除术联合经内镜下套扎序贯硬化剂治疗对门静脉高压症病人的疗效及对其血流动力学及预后的影响[J]. 临床外科杂志, 2022, 30(7): 691-693.
[4] 李宗富 陈铁良 丁梅 王增辉 陈建利. 快速康复外科对早期胃癌腹腔镜辅助保留幽门胃切除术患者营养状态的影响分析[J]. 临床外科杂志, 2022, 30(5): 433-436.
[5] 阮添 李昌盛 杨泽天 周雪峰 王乐. 内脏胸膜侵犯对术后ⅢA/N2期非小细胞肺癌病人生存的影响:SEER数据库分析[J]. 临床外科杂志, 2022, 30(5): 448-452.
[6] 叶彬 向秋 金文杰. 叉头框蛋白Q1和细胞周期蛋白D1在非小细胞肺癌组织中的表达与临床病理特征及预后的关系[J]. 临床外科杂志, 2022, 30(5): 453-458.
[7] 詹浩东 王荣 李剑. 改良格拉斯哥预后评分联合纤维蛋白原与前白蛋白比值对胸腔镜肺叶切除术治疗肺癌的预后评估价值[J]. 临床外科杂志, 2022, 30(5): 459-462.
[8] 卞春安 田晓奇 林超宇 许里. CRYAB在肺鳞癌中的表达及其临床意义[J]. 临床外科杂志, 2022, 30(5): 486-489.
[9] 杨恒 张军 郭强 林称意 罗卫民 原野 程栋梁 罗湘玉 刘华 郭家龙. 基于多数据库分析HLA-DPB1在肺腺癌中的潜在价值[J]. 临床外科杂志, 2022, 30(4): 339-344.
[10] 金一 王昕仪 杜润森 郑丽华 赵亚恒 杨艳. 乳腺癌组织hsa-mir-337表达降低的临床意义与预后分析[J]. 临床外科杂志, 2022, 30(4): 345-348.
[11] 王鹏远 尚义超 郑铎 尚攀峰 岳中瑾. 肾盂癌与输尿管癌术后预后分析[J]. 临床外科杂志, 2022, 30(4): 368-371.
[12] 李铃睿 宋俊龙 刘汉卿 孔德光 陈创. 甲状腺乳头状癌的基因变异与临床病理特点分析[J]. 临床外科杂志, 2022, 30(3): 222-225.
[13] 卢开进 申江峰 贾卫光. 胸腔镜改良喉返神旁经淋巴结清扫治疗食管癌的疗效及对预后的影响[J]. 临床外科杂志, 2022, 30(3): 257-260.
[14] 沈荐 李敏哲 杜燕夫. 中心型肥胖对腹腔镜远端胃癌D2根治术临床疗效的影响[J]. 临床外科杂志, 2022, 30(3): 261-265.
[15] 李玉柱 夏连杰. 膀胱癌病人癌组织中Dickkopf相关蛋白2的表达及与预后的相关性[J]. 临床外科杂志, 2022, 30(3): 280-283.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 昌盛. 中国心脏死亡捐献供肾器官的维护[J]. 临床外科杂志, 2016, 24(10): 744 .
[2] 阿布力克木·毛拉尤甫;郑秉礼. 胰腺实性假乳头状瘤45例手术治疗分析[J]. 临床外科杂志, 2016, 24(10): 764 .
[3] 胡志伟;汪忠镐;张玉;等. 腹腔镜Toupet胃底折叠术治疗干燥综合征合并严重胃食管反流病两例[J]. 临床外科杂志, 2016, 24(10): 766 .
[4] 李义亮;张成;克力木;等. 完全腹腔镜下远端胃癌根治术的临床体会[J]. 临床外科杂志, 2016, 24(10): 769 .
[5] 李光焰;张安平;王祥峰;等. 直肠癌切除术后吻合口狭窄14例分析[J]. 临床外科杂志, 2016, 24(10): 772 .
[6] 张忠伟;刘扬;路明. 痔上黏膜环切术治疗直肠前突所致出口梗阻型便秘的疗效观察[J]. 临床外科杂志, 2016, 24(10): 774 .
[7] 肖国栋;刘国辉. 跗骨窦切口联合经皮置钉技术微创治疗跟骨骨折的临床疗效分析[J]. 临床外科杂志, 2016, 24(10): 783 .
[8] 陈绍站;许勇;李婧;等. 防旋股骨近端髓内针与股骨近端解剖锁定钢板治疗转子间骨折的疗效比较[J]. 临床外科杂志, 2016, 24(10): 787 .
[9] 戴强;徐康;周治军;等. 湖北天门地区泌尿系结石成分及特征分析[J]. 临床外科杂志, 2016, 24(10): 789 .
[10] 刘琼;江辉. 喉罩在小儿舌系带矫正手术中的应用[J]. 临床外科杂志, 2016, 24(10): 792 .